Table of Contents

Global Oral Anti-Diabetic Drug Market Growth 2019-2024

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Oral Anti-Diabetic Drug Consumption 2014-2024
  • 2.1.2 Oral Anti-Diabetic Drug Consumption CAGR by Region
• 2.2 Oral Anti-Diabetic Drug Segment by Type
  • 2.2.1 Glimepiride
  • 2.2.2 Gliclazide
  • 2.2.3 Glyburide
  • 2.2.4 Others
• 2.3 Oral Anti-Diabetic Drug Consumption by Type
  • 2.3.1 Global Oral Anti-Diabetic Drug Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Oral Anti-Diabetic Drug Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Oral Anti-Diabetic Drug Sale Price by Type (2014-2019)
• 2.4 Oral Anti-Diabetic Drug Segment by Application
  • 2.4.1 Hospital
  • 2.4.2 Research Institual
• 2.5 Oral Anti-Diabetic Drug Consumption by Application
  • 2.5.1 Global Oral Anti-Diabetic Drug Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Oral Anti-Diabetic Drug Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Oral Anti-Diabetic Drug Sale Price by Application (2014-2019)

3 Global Oral Anti-Diabetic Drug by Manufacturers

• 3.1 Global Oral Anti-Diabetic Drug Sales Market Share by Manufacturers
  • 3.1.1 Global Oral Anti-Diabetic Drug Sales by Manufacturers (2017-2019)
  • 3.1.2 Global Oral Anti-Diabetic Drug Sales Market Share by Manufacturers (2017-2019)
• 3.2 Global Oral Anti-Diabetic Drug Revenue Market Share by Manufacturers
  • 3.2.1 Global Oral Anti-Diabetic Drug Revenue by Manufacturers (2017-2019)
  • 3.2.2 Global Oral Anti-Diabetic Drug Revenue Market Share by Manufacturers (2017-2019)
• 3.3 Global Oral Anti-Diabetic Drug Sale Price by Manufacturers
• 3.4 Global Oral Anti-Diabetic Drug Manufacturing Base Distribution, Sales Area, Product Types by Manufacturers
  • 3.4.1 Global Oral Anti-Diabetic Drug Manufacturing Base Distribution and Sales Area by Manufacturers
  • 3.4.2 Players Oral Anti-Diabetic Drug Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Oral Anti-Diabetic Drug by Regions

• 4.1 Oral Anti-Diabetic Drug by Regions
  • 4.1.1 Global Oral Anti-Diabetic Drug Consumption by Regions
  • 4.1.2 Global Oral Anti-Diabetic Drug Value by Regions
• 4.2 Americas Oral Anti-Diabetic Drug Consumption Growth
• 4.3 APAC Oral Anti-Diabetic Drug Consumption Growth
• 4.4 Europe Oral Anti-Diabetic Drug Consumption Growth
• 4.5 Middle East & Africa Oral Anti-Diabetic Drug Consumption Growth

5 Americas

• 5.1 Americas Oral Anti-Diabetic Drug Consumption by Countries
  • 5.1.1 Americas Oral Anti-Diabetic Drug Consumption by Countries (2014-2019)
  • 5.1.2 Americas Oral Anti-Diabetic Drug Value by Countries (2014-2019)
• 5.2 Americas Oral Anti-Diabetic Drug Consumption by Type
• 5.3 Americas Oral Anti-Diabetic Drug Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Oral Anti-Diabetic Drug Consumption by Countries
  • 6.1.1 APAC Oral Anti-Diabetic Drug Consumption by Countries (2014-2019)
  • 6.1.2 APAC Oral Anti-Diabetic Drug Value by Countries (2014-2019)
• 6.2 APAC Oral Anti-Diabetic Drug Consumption by Type
• 6.3 APAC Oral Anti-Diabetic Drug Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Oral Anti-Diabetic Drug by Countries
  • 7.1.1 Europe Oral Anti-Diabetic Drug Consumption by Countries (2014-2019)
  • 7.1.2 Europe Oral Anti-Diabetic Drug Value by Countries (2014-2019)
• 7.2 Europe Oral Anti-Diabetic Drug Consumption by Type
• 7.3 Europe Oral Anti-Diabetic Drug Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Oral Anti-Diabetic Drug by Countries
  • 8.1.1 Middle East & Africa Oral Anti-Diabetic Drug Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Oral Anti-Diabetic Drug Value by Countries (2014-2019)
• 8.2 Middle East & Africa Oral Anti-Diabetic Drug Consumption by Type
• 8.3 Middle East & Africa Oral Anti-Diabetic Drug Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Oral Anti-Diabetic Drug Distributors
• 10.3 Oral Anti-Diabetic Drug Customer

11 Global Oral Anti-Diabetic Drug Market Forecast

• 11.1 Global Oral Anti-Diabetic Drug Consumption Forecast (2019-2024)
• 11.2 Global Oral Anti-Diabetic Drug Forecast by Regions
  • 11.2.1 Global Oral Anti-Diabetic Drug Forecast by Regions (2019-2024)
  • 11.2.2 Global Oral Anti-Diabetic Drug Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Oral Anti-Diabetic Drug Forecast by Type
• 11.8 Global Oral Anti-Diabetic Drug Forecast by Application

12 Key Players Analysis

• 12.1 Janssen Pharmaceuticals
  • 12.1.1 Company Details
  • 12.1.2 Oral Anti-Diabetic Drug Product Offered
  • 12.1.3 Janssen Pharmaceuticals Oral Anti-Diabetic Drug Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Janssen Pharmaceuticals News
• 12.2 Novartis
  • 12.2.1 Company Details
  • 12.2.2 Oral Anti-Diabetic Drug Product Offered
  • 12.2.3 Novartis Oral Anti-Diabetic Drug Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 Novartis News
• 12.3 Pfizer
  • 12.3.1 Company Details
  • 12.3.2 Oral Anti-Diabetic Drug Product Offered
  • 12.3.3 Pfizer Oral Anti-Diabetic Drug Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 Pfizer News
• 12.4 Takeda
  • 12.4.1 Company Details
  • 12.4.2 Oral Anti-Diabetic Drug Product Offered
  • 12.4.3 Takeda Oral Anti-Diabetic Drug Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Takeda News
• 12.5 Astellas
  • 12.5.1 Company Details
  • 12.5.2 Oral Anti-Diabetic Drug Product Offered
  • 12.5.3 Astellas Oral Anti-Diabetic Drug Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 Astellas News
• 12.6 Eli Lilly
  • 12.6.1 Company Details
  • 12.6.2 Oral Anti-Diabetic Drug Product Offered
  • 12.6.3 Eli Lilly Oral Anti-Diabetic Drug Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 Eli Lilly News
• 12.7 AstraZeneca
  • 12.7.1 Company Details
  • 12.7.2 Oral Anti-Diabetic Drug Product Offered
  • 12.7.3 AstraZeneca Oral Anti-Diabetic Drug Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 AstraZeneca News
• 12.8 Boehringer Ingelheim
  • 12.8.1 Company Details
  • 12.8.2 Oral Anti-Diabetic Drug Product Offered
  • 12.8.3 Boehringer Ingelheim Oral Anti-Diabetic Drug Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.8.4 Main Business Overview
  • 12.8.5 Boehringer Ingelheim News
• 12.9 Bristol Myers Squibb
  • 12.9.1 Company Details
  • 12.9.2 Oral Anti-Diabetic Drug Product Offered
  • 12.9.3 Bristol Myers Squibb Oral Anti-Diabetic Drug Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.9.4 Main Business Overview
  • 12.9.5 Bristol Myers Squibb News
• 12.10 Merck And Co.
  • 12.10.1 Company Details
  • 12.10.2 Oral Anti-Diabetic Drug Product Offered
  • 12.10.3 Merck And Co. Oral Anti-Diabetic Drug Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.10.4 Main Business Overview
  • 12.10.5 Merck And Co. News
• 12.11 Sanofi
• 12.12 Biocon
• 12.13 Abbott

13 Research Findings and Conclusion

According to this study, over the next five years the Oral Anti-Diabetic Drug market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Oral Anti-Diabetic Drug business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Oral Anti-Diabetic Drug market by product type, application, key manufacturers and key regions and countries.

This study considers the Oral Anti-Diabetic Drug value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Glimepiride
Gliclazide
Glyburide
Others

Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital
Research Institual

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Janssen Pharmaceuticals
Novartis
Pfizer
Takeda
Astellas
Eli Lilly
AstraZeneca
Boehringer Ingelheim
Bristol Myers Squibb
Merck And Co.
Sanofi
Biocon
Abbott

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Oral Anti-Diabetic Drug consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Oral Anti-Diabetic Drug market by identifying its various subsegments.
Focuses on the key global Oral Anti-Diabetic Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Oral Anti-Diabetic Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Oral Anti-Diabetic Drug submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.